Co-Leader, Sylvester Neuro-Oncology Site Disease Group
Medical Director, Stereotactic Radiotherapy, Department of Radiation Oncology
Biography
Dr. Mellon decided to become a doctor after watching the struggles of several family members with cancer and other serious medical illnesses. He approaches every patient with the promises he made to his sick parents: explain everything clearly to non-doctors, take as much time as needed to answer all questions, and treat patients as if they were family.
Shortly after arriving at the University of Miami in 2016, Dr. Mellon took the lead of radiation oncology for brain and spine tumors. He is proud to work every day with a close team of UM and Jackson neurosurgeons, neuro-oncologists, and others to provide the most advanced and compassionate care possible. Dr. Mellon also works hard to balance research with clinical care. He currently leads or develops several clinical trials and other studies of new treatments for brain and spine tumors. He attends and presents at conferences with the broader community of brain tumor specialists to discuss the latest treatment developments.
Education & Training
Education
2011: University of Pennsylvania , Philadelphia, PA
MD, Medical Scientist Training Program
2011: University of Pennsylvania , Philadelphia
PhD, Boichemistry and Molecular Biphysics (MRI Physics)
2003: University of Delaware , Newark, NJ
BA, Biology and Psychology
Post Graduate Training
2016: University of Pittsburgh, Pittsburgh, PA
Other, Gamma Knife Radiation Prefexion
2016: Moffit Cancer Center/University of South Florida, Tampa, FL
Residency, Radiation Oncology
2014: University of Florida , Jacksonville, FL
Clerkship, Proton Therapy Rotation
2012: Aurora St. Luke's Medical Center , Milwaukee, WI
Internship
2009: University of Utah, Salt Lake City, Utah
Post-Doctoral Fellowship
Honors & Awards
No result found
Teaching Interests
Brain tumors, spine tumors, radiation oncology, and MRI
Research Interests
My research interests are response prediction by imaging, tissue, and blood biomarkers for adaptive therapy of glioblastoma as well as novel MRI techniques for radiation therapy planning and delivery for brain and spine tumors.
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
